Calidi Biotherapeutics (CLDI) Non-Current Debt (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Non-Current Debt of $200000.0 for Q4 2025, down 92.59% year-over-year from $2.7 million in Q4 2024, and down 50.0% quarter-over-quarter from $400000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Non-Current Debt (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Non-Current Debt history runs 4 years deep, the most recent figure standing at $200000.0 for Q4 2025.
- In Q4 2025, Non-Current Debt fell 92.59% year-over-year to $200000.0; the TTM figure through Dec 2025 stood at $200000.0 (down 92.59% YoY), while the FY2025 annual figure was $200000.0, down 92.59% from the prior year.
- Non-Current Debt for Q4 2025 stood at $200000.0, down from $400000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $3.3 million in Q3 2023, with the low at $200000.0 in Q4 2025.
- The 4-year median for Non-Current Debt is $2.1 million (2023), against an average of $1.8 million.
- The sharpest annual moves came in 2023 and 2025: Non-Current Debt soared 37.33% in 2023, then tumbled 92.59% in 2025.
- Calidi Biotherapeutics' Non-Current Debt stood at $1.5 million in 2022, then surged by 37.33% to $2.1 million in 2023, then jumped by 31.07% to $2.7 million in 2024, then sank by 92.59% to $200000.0 in 2025.
- Business Quant data shows CLDI's Non-Current Debt at $200000.0 in Q4 2025, $400000.0 in Q3 2025, and $800000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Dec 31, 2022 | 1.50 Mn |